This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: E-Therapeutics Plc. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Julie Borgel: Innovator in Diabetes Treatment
Introduction
Julie Borgel is a prominent inventor based in London, GB. She has made significant contributions to the field of diabetes treatment through her innovative research and development. Her work focuses on inhibitors that can potentially transform the management of this chronic condition.
Latest Patents
Julie holds 1 patent related to her invention titled "Inhibitors of expression and/or function." This invention pertains to inhibitors and compositions that can be utilized in the treatment or prevention of diabetes. Her research aims to provide new therapeutic options for individuals affected by this disease.
Career Highlights
Throughout her career, Julie has worked with notable companies such as E-Therapeutics Plc and Tangram Therapeutics Plc. Her experience in these organizations has allowed her to advance her research and contribute to the development of innovative solutions in the healthcare sector.
Collaborations
Julie has collaborated with esteemed colleagues, including Viviana Mannella and Muthusamy Jayaraman. These partnerships have enriched her research endeavors and fostered a collaborative environment for innovation.
Conclusion
Julie Borgel's work exemplifies the impact of innovation in the field of diabetes treatment. Her dedication to developing effective therapies highlights the importance of research and collaboration in addressing health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile